The cell and gene industry possesses forward-looking and disruptive characteristics, aiming to solve the challenges of treating major diseases such as genetic disorders and cancer. From a strategic perspective, the inclusion of cell and gene therapy as a key future industry for development in Guangzhou is a vivid example of this logic. By 2030, Guangzhou plans to establish a complete industrial ecosystem, forming a cluster exceeding 100 billion yuan in value, and becoming a global innovation hub and leading center for cell and gene therapy development.
In September 22-23, Guangzhou becomes the home of the China’s leading cell and gene therapy forum, bringing together 1,200+ biotech, pharma, CDMO, and investment leaders. Innoxbio CGT 2026 delivers a high-impact experience where scientific progress meets strategic partnership and commercialization. From emerging science to scalable solutions, this is the must-attend biotech event for anyone shaping the future of CGT.
Whether you’re scaling a new therapy, forming critical partnerships, or navigating regulatory change, Innoxbio CGT 2026 is the must-attend cell & gene therapy forum for biotech and pharma leaders.
Expand Your Network: Connect with 1,200+ leaders from biotech, pharma, CDMOs, and investors
Gain Actionable Insight: Hear 80+ speakers tackling the most urgent challenges in clinical development, manufacturing scale-up, commercialization, and global market access.
Discover the Future of Innovation: Explore next-gen platforms, novel technologies, and emerging trends transforming CGT worldwide.
Insight That Moves You
Forward